Advances in immunotyping of colorectal cancer
Immunotherapy has transformed treatment for various types of malignancy. However, the benefit of immunotherapy is limited to a minority of patients with mismatch-repair-deficient (dMMR) and microsatellite instability-high (MSI-H) (dMMR-MSI-H) colorectal cancer (CRC). Understanding the complexity and...
Saved in:
Published in | Frontiers in immunology Vol. 14; p. 1259461 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Frontiers Media S.A
09.10.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!